Overview

Prophylactic Antibiotics Before RFA for HCC

Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This randomized prospective study aims to investigate whether prophylactic administration of antibiotics has an influence on inflammatory markers, liver function test results, or the incidence of post-procedural infection in patients with hepatocellular carcinoma (HCC) undergoing radiofrequency ablation (RFA).
Phase:
Phase 4
Details
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Collaborator:
Taipei Medical University Hospital
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Cefazolin